https://www.uclahealth.org/news/release/dr-luca-valle-receives-va-grant-improve-prediction
Dr. Luca Valle receives VA grant to improve prediction of radiorecurrent prostate cancer outcomes |...
Dr. Luca Valle was awarded a $2.1 million grant from the U.S. Department of Veterans Affairs to develop new methods to better understand the clinical scope and...
https://pubmed.ncbi.nlm.nih.gov/40822992/
Interstitial High-Dose-Rate Brachytherapy for Radiorecurrent Atypical Meningioma: A Brief Report
Interstitial High-Dose-Rate Brachytherapy for Radiorecurrent Atypical Meningioma: A Brief Report
high dose